|IL-6 pathway inhibitors|1 dosing interval¶|4 weeks|
|IL-1 inhibitors|1 dosing interval¶|4 weeks|
|Anakinra|1 dosing interval¶|4 weeks|
|Rilonacept|1 dosing interval¶|4 weeks|
|Canakinumab|1 dosing interval¶|4 weeks|
|Abatacept|1 dosing interval§|4 weeks|
|Anifrolumab|1 dosing interval§|4 weeks|
|Cyclophosphamide, intravenous|1 dosing interval§|4 weeks|
|Rituximab|6 months|4 weeks|
| <strong>IVIG#</strong>  |  |  |<br />
| 300–400 mg/kg     | 8 months     |  4 weeks |